Characterization of the different S6Ks isoforms interacting partners
© Pavan et al; licensee BioMed Central Ltd. 2014
Published: 28 May 2014
mTOR signaling pathway has been related to several human diseases and disorders, including obesity, diabetes and many types of cancer. In the cell, mTOR signaling is responsible to induce cell growth and metabolism upon activation by signals from nutrients processing, such as insulin, ATP and amino acids. S6Ks, which phosphorylates ribosomal S6 protein, are effectors of the mTOR pathway. S6K family is composed of two genes (encoding S6K1 and S6K2) and different isoforms from alternative translation initiation (p70-S6K1, p85-S6K1, p54-S6K2, p56S6K2) and alternative splicing (p31-S6K1). The main function of S6Ks, upon activation, is to lead increased protein synthesis. Nevertheless, one of the main questions in this field is to address the specific roles of the different S6Ks isoforms. In this study, we overexpressed p70-S6K1, p85-S6K1 and p54-S6K2 in human cells and analyzed by immunoprecipitation, followed by mass spectrometry identification, the different interacting partners of those S6Ks isoforms. The different roles of S6Ks isoforms were also evaluated in an adipocyte model and in cancer cell lines. Our study provide new possible functions to the different S6Ks isoforms which may help the understanding of their roles in the mTOR signaling pathway, metabolism and cancer.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.